Barclays Maintains Overweight on Braze, Raises Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Ryan Macwilliams has maintained an Overweight rating on Braze (NASDAQ:BRZE) and increased the price target from $65 to $80.
December 07, 2023 | 11:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Ryan Macwilliams maintains an Overweight rating on Braze and raises the price target from $65 to $80, indicating a positive outlook on the stock.
The increase in price target by a major financial institution like Barclays suggests a strong confidence in Braze's future performance. This typically leads to increased investor confidence and can result in a short-term rise in the stock price, as the market adjusts to the new analyst expectations.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100